Beam Therapeutics Inc.
BEAM
$17.00
$0.382.29%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 6.53% | -6.17% | 7.72% | -169.10% | 248.61% |
| Total Depreciation and Amortization | -0.58% | -1.81% | 2.67% | 1.29% | 3.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.21% | 1.01% | -9.77% | 70.71% | -11.24% |
| Change in Net Operating Assets | 18.93% | 1.22% | 31.74% | -20.47% | -60.43% |
| Cash from Operations | 13.34% | -6.16% | 16.78% | -173.85% | 250.44% |
| Capital Expenditure | -88.33% | 19.58% | 19.57% | 32.07% | 54.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 391.91% | -70.63% | 275.31% | -150.18% | 4,556.09% |
| Cash from Investing | 411.30% | -71.77% | 263.65% | -154.50% | 1,058.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -87.85% | 39.55% | 71.99% | -58.00% |
| Issuance of Common Stock | 135.41% | 509.58% | -92.19% | -91.05% | -8.56% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | 172.90% | 848.87% | -95.41% | -91.41% | -8.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 185.83% | -1,446.44% | 103.07% | -156.32% | 522.04% |